Swiss competition watchdog probes Novartis over patent useBusiness, TherapeuticsThe Swiss competition commission (COMCO) has opened an investigation of Novartis over possible unlawful use of a patent to reduce competitive pressure, the Swiss drugmaker confirmed on Thursday. Read more September 15, 2022/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2022/06/ReutersNovartis6-6-2022.webp 795 1200 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2022-09-15 02:07:482022-09-15 20:02:07Swiss competition watchdog probes Novartis over patent use
